scispace - formally typeset
D

David Enot

Researcher at Institut Gustave Roussy

Publications -  80
Citations -  11106

David Enot is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Immune system & Immunosurveillance. The author has an hindex of 41, co-authored 80 publications receiving 8718 citations. Previous affiliations of David Enot include University of Paris-Sud & Aberystwyth University.

Papers
More filters
Journal ArticleDOI

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

TL;DR: A key role is revealed for Bacteroidales in the immunostimulatory effects of CTLA-4 blockade, which is found to depend on distinct Bacteroides species in mice and patients.
Journal ArticleDOI

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

TL;DR: It is demonstrated that cyclophosphamide alters the composition of microbiota in the small intestine and induces the translocation of selected species of Gram-positive bacteria into secondary lymphoid organs, which suggests that the gut microbiota help shape the anticancer immune response.
Journal ArticleDOI

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

TL;DR: The data suggest that anthracycline-mediated immune responses mimic those induced by viral pathogens, and it is surmised that such 'viral mimicry' constitutes a hallmark of successful chemotherapy.
Journal ArticleDOI

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

TL;DR: Enterococcus hirae and B. intestinihominis represent valuable "oncomicrobiotics" ameliorating the efficacy of the most common alkylating immunomodulatory compound CTX, and selectively predicted longer progression-free survival in advanced lung and ovarian cancer patients treated with chemo-immunotherapy.